Advertisement

Topics

Tiens Biotech Group Company Profile

11:02 EST 19th December 2018 | BioPortfolio

Tiens Biotech Group (USA), Inc. ("Tiens USA") is a United States corporation, organized under the laws of the State of Delaware. Tiens conducts most of its business through two of its subsidiaries: Tianjin Tianshi Biological Development Co., Ltd. ("Biological"), and Tiens Yihai Co., Ltd. ("Tiens Yihai"). Established in 1998, Biological is primarily engaged in the research, development, manufacturing and marketing of nutrition supplements and personal care products. Its products are sold in approximately 90 countries internationally and over 31 provinces domestically in China. In April 2004 Tiens' wholly-owned subsidiary, Tianshi International Holding Group Ltd. entered into a joint venture agreement with Tianjin Tianshi Pharmaceutical Co., Ltd. to establish Tiens Yihai, a Chinese-Foreign Equity Joint Venture. Located in Shanghai,China, Tiens Yihai is in the business of research and development, production and marketing of nutrition supplements products, home care and personal care products. The total investment amount is projected to be approximately $400million.

Location

No.6, Yuanquan Road
Wuqing Development Area
Tianjin New Tech Industrial park
P.R
301700
China

Contact

Phone: +86-22-8213-7915
Fax: +86-22-8213-7667
Email: info@tiens-bio.com


News Articles [2340 Associated News Articles listed on BioPortfolio]

TIENS Group abre su nueva Experience Store equipada con alta tecnología en Shenzhen

SHENZHEN, China, 9 de agosto de 2018 /PRNewswire/ -- TIENS Group, una de las empresas líderes del sector sanitario, ha presentado una nueva Experience Store Read more...

TIENS Group Launches Global Expansion Into New Retail

TIANJIN, China, Nov. 12, 2018 /PRNewswire/ -- Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Exp...

AbbVie doubles down on cancer project with biotech group Argenx

Biotech group Argenx said on Wednesday U.S. pharma group AbbVie had exercised an exclusive option to develop and commercialize one of its experimental drugs which could lead to payments of up to $625 ...

#jobs #lifescience CK Group: EHS Manager – Dun Laoghaire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: EHS Manager – Dun Laoghaire . Up to €60 per hour Ltd: CK Gr...

EDB Group: Carola Schropp on the Role of EBD Group conferences in partnering and deal making

In this episode of PharmaTelevsion News Review, Fintan Walton discusses the recent BioPharm America conference in Boston with Carola Schropp from the EBD Group. • Role of EBD Group conferences in p...

#jobs #lifescience CK Group: Maintenance Technician – Inverness

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Maintenance Technician – Inverness . £19.67 per hour: CK Gro...

#jobs #lifescience CK Group: QC Analyst in Dundee

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: QC Analyst in Dundee . £22000 – £34000 per annum: CK Group:...

5 Top Weekly NASDAQ Biotech Stocks: MiMedx Group Leads

MiMedx Group, Avid Bioservices, Lifevantage, EyePoint Pharmaceuticals and BioLife Solutions were last week's top gainers on the NASDAQ Biotechnology Index. The post 5 Top Weekly NASDAQ Biotech Stocks...

Drugs and Medications [52 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [4140 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Companies [2560 Associated Companies listed on BioPortfolio]

Tiens Biotech Group (USA), Inc.

Tiens Biotech Group (USA), Inc. (NYSE AMEX: TBV) conducts its business operations from Tianjin, People's Republic of China. Tiens primarily engages in the research, development, manufacturing, and...

Tiens Biotech Group

Tiens Biotech Group (USA), Inc. ("Tiens USA") is a United States corporation, organized under the laws of the State of Delaware. Tiens conducts most of its business through two of its subs...

BioTech Capital Limited

BioTech Capital Ltd is one of Australia's largest pure biotechnology investment funds specialising in unlisted, early stage opportunities. It has a strategic partnership with Foursight Associates - a...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

More Information about "Tiens Biotech Group" on BioPortfolio

We have published hundreds of Tiens Biotech Group news stories on BioPortfolio along with dozens of Tiens Biotech Group Clinical Trials and PubMed Articles about Tiens Biotech Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tiens Biotech Group Companies in our database. You can also find out about relevant Tiens Biotech Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record